Join
Live feed
·
INSIDERFilingvia Quantisnow
ReShape Lifesciences Inc. logo

SEC Form 4: Stankovich Thomas was granted 372,744 units of Common Stock and sold $139,778 worth of Common Stock (48,366 units at $2.89), increasing direct ownership by 965% to 357,991 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RSLS (ReShape Lifesciences Inc.) and more on Quantisnow.